Is Kretto Syscon overvalued or undervalued?

As of 14 November 2025, Kretto Syscon's valuation grade has moved from expensive to fair, indicating a more favorable assessment of its market position. The company is currently fairly valued, with a PE ratio of 13.14, an EV to EBITDA of 11.68, and a PEG ratio of 0.14, which suggests strong growth potential relative to its price.
In comparison to its peers, Kretto Syscon stands out with a significantly lower PE ratio than Apollo Hospitals, which is rated attractive at a PE of 63.77, and Max Healthcare, which is very expensive at a PE of 89.07. This positions Kretto Syscon as a more appealing investment within the realty sector, particularly given its reasonable valuation metrics. Despite recent stock performance lagging behind the Sensex, especially over the past year with a decline of 26% compared to the Sensex's 9% gain, the long-term outlook remains promising with a 3-year return of 113.55%.